Leven Life Sciences Private Limited
About Leven Life Sciences Private Limited
Data last updated:
Leven Life Sciences Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC091021. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Chandrasekhar Mantrapudi (Managing Director) and Mantrapudi Madhusudhana Rao.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Secunderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹41,530, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹55,876 (net margin -134.5%) and EBITDA of -₹54,964 (EBITDA margin -132.3%).
The company has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in March 2015. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Abbott Pharma Limited with revenue of ₹42,999.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1 – 19 – 80/159 1st Floor Near Temple A.S.Rao Nagar Vijayapuri Col, Ony, Secunderabad, Telangana, India – 500062
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Leven Life Sciences Private Limited
The main business activity of Leven Life Sciences is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Leven Life Sciences Private Limited FY 2024 filings available
Leven Life Sciences Private Limited reported revenue of ₹41,530 (up 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Leven Life Sciences Private Limited
Revenue rose 5% in the latest year. EBITDA fell 144% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Leven Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹54,964 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹55,876 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Leven Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -132.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -134.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Leven Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Leven Life Sciences Private Limited
Leven Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abbott Pharma Limited | ₹42,999 (FY 2024) | •••• | •••• | -39.0% | •••• | Delhi, India |
| Right Choice Care Private Limited | ₹42,810 (FY 2024) | •••• | •••• | 46.0% | •••• | Lucknow, Uttar Pradesh, India |
| Chandra Medical Mission Private Limited | ₹42,730 (FY 2021) | •••• | •••• | -28.0% | •••• | Chennai, Tamil Nadu, India |
| Rescure Remedies Private Limited | ₹42,630 (FY 2025) | •••• | •••• | -99.0% | •••• | Chandigarh, India |
| Inverno (OPC) Private Limited | ₹41,585 (FY 2020) | •••• | •••• | 8.0% | •••• | Indore, Madhya Pradesh, India |
| Leven Life Sciences Private Limited this company | ₹41,530 (FY 2024) | •••• | •••• | 5.0% | •••• | Secunderabad, Telangana, India |
| Aaradhya Utpal Sales and Services Private Limited | ₹41,302 (FY 2024) | •••• | •••• | •••• | Bhojpur, Bihar, India | |
| G Ways Marketing Limited | ₹40,312 (FY 2025) | •••• | •••• | 838.0% | •••• | New Delhi, Delhi, India |
| Parkin Health Care Private Limited | ₹39,865 (FY 2021) | •••• | •••• | -87.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Ecosol Industries Private Limited | ₹39,554 (FY 2024) | •••• | •••• | -95.0% | •••• | New Delhi, Delhi, India |
| Nirved Industries Private Limited | ₹39,145 (FY 2021) | •••• | •••• | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Leven Life Sciences by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Leven Life Sciences Private Limited
Leven Life Sciences Private Limited is audited by MEENAVALLI & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MEENAVALLI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Leven Life Sciences Private Limited
Leven Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mantrapudi Madhusudhana Rao Also directs: Sis Tele Services Private Limited, Spring Fiber Private Limited | Director | 14 Nov 2013 | 12 Years 10 Months | Current |
| Chandrasekhar Mantrapudi Also directs: Sis Tele Services Private Limited, Spring Fiber Private Limited | Managing Director | 14 Nov 2013 | 12 Years 10 Months | Current |
Ownership and Shareholding of Leven Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Leven Life Sciences Private Limited
Leven Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Leven Life Sciences Private Limited
Leven Life Sciences Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in March 2015.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2015 | Funding round | ₹49 Lakh | Investors: Sis Tele Services Private Limited , 2 individuals |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Leven Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Leven Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Leven Life Sciences Private Limited
Leven Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2013PTC091021. The current CIN is U24232TG2013PTC091021, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC091021 | Current |
| U24232AP2013PTC091021 | Previous |
Recent Activity on Leven Life Sciences Private Limited
Leven Life Sciences Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Seetharama Raju Mudunuri ceased to be Additional Director on 01 Nov 2019.
Credit Ratings, Litigation & Regulatory Alerts for Leven Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Leven Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Leven Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Leven Life Sciences Private Limited
Leven Life Sciences has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Leven Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leven Life Sciences Private Limited
Leven Life Sciences is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 November 2013 (13+ years old) and is registered under CIN U24232TG2013PTC091021.
Leven Life Sciences reported revenue of ₹41,530 for FY 2024 (up 5% YoY).
Leven Life Sciences has 2 current directors:
- Chandrasekhar Mantrapudi - Managing Director
- Mantrapudi Madhusudhana Rao - Director
Leven Life Sciences reported a net loss of ₹55,876 (net margin -134.5%) and EBITDA of -₹54,964 (EBITDA margin -132.3%) for FY 2024, as per its filed financial statements.
No. Leven Life Sciences has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Leven Life Sciences is U24232TG2013PTC091021. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leven Life Sciences was incorporated on 14 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
Leven Life Sciences has 1 deal on record (1 funding round), with disclosed funding of ₹49 Lakh; the latest was in March 2015.
The peers of Leven Life Sciences by revenue are Abbott Pharma Limited, Right Choice Care Private Limited, Chandra Medical Mission Private Limited, Rescure Remedies Private Limited, Inverno (OPC) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Seetharama Raju Mudunuri ceased to be Additional Director on 01 Nov 2019. Chandrasekhar Mantrapudi was appointed as Managing Director on 14 Nov 2013. Mantrapudi Madhusudhana Rao was appointed as Director on 14 Nov 2013.
The registered office of Leven Life Sciences is at 1 – 19 – 80159 1st Floor Near Temple A.S.Rao Nagar Vijayapuri Col, Ony, Secunderabad, Telangana, India – 500062.